Author

E.-K. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

B.-G. Jeong· 1 shared D. Kang· 1 shared D.-W. Bae· 1 shared G. S. Lee· 1 shared H. H. Jang· 1 shared H.-S. Yim· 1 shared J. H. Cho· 1 shared J. H. Moon· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

B.-G. Jeong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Temperature-responsive structural reversibility of FGF21 and structure-based design of its variant with enhanced potency

Y.-E. Jung, K. W. Lee, J. H. Cho, D.-W. Bae, B.-G. Jeong, Y.-J. Jung, Y. J. An, K. Kim, G. S. Lee, L.-W. Kang, J. H. Moon, J.-H. Lee, E.-K. Kim, H.-S. Yim, S.-S. Cha

This study investigates the thermal behavior of FGF21 and designs a variant with enhanced therapeutic potency through structural analysis and mutagenesis.

bioRxiv · Nov 16, 2021 · PreprintBiochemistry

SILAC-Based Quantitative Proteomics Identifies Multifactorial Mechanism of Oxaliplatin Resistance in Pancreatic Cancer Cells

Y. E. Kim, E.-K. Kim, M.-J. Song, T.-Y. Kim, H. H. Jang, D. Kang

This study uses SILAC-based proteomics to identify proteins involved in oxaliplatin resistance in pancreatic cancer cells, finding that MARCKS and WLS contribute to resistance through AKT and β-catenin signaling.

bioRxiv · Sep 4, 2020 · PreprintCancer Biology